Oct. 24 at 3:40 AM
Wait ... you mean the CEO of
$ANVS Dr. Maccecchini is not a liar??? What?!?
I don't have too much time on my hands, but I do have enough time to take a few minutes to draft this quick post.
If I had more time the post would be ginormous 🤥👐
This writeup represents just the ...
"Low Lying FruitFruit 🍌" 😂
Synopsis: Dr. Maria Maccecchini’s Pattern of False Promises and Investor Misrepresentation
Across multiple public forums between June 2024 and February 2025, Dr. Maria Maccecchini, CEO of Annovis Bio, repeatedly made unverified, exaggerated, and financially misleading claims about the company’s partnerships, funding, and clinical readiness—creating a pattern of false assurances to investors and patients.
(1) Virtual Investor Presentation – June 18, 2024: “Annovis Bio's Breakthroughs in Alzheimer’s and Parkinson’s”
During this investor pitch, Dr. Maccecchini suggested imminent international Phase 3 trials and partnerships despite no supporting regulatory approvals or signed collaborations.
She claimed:
“Easier to do is to partner with a country and then do a joint venture in that country ... Japan 🇯🇵 we would do the same Phase 3 ... in the United States 🇺🇸 ... we can do the same with China 🇨🇳 we can do the same with ... probably not Russia 🇷🇺 (because Dr. Maccecchini has morals) ... but, with a country in Europe 🇪🇺 or a country in whatever ... I can’t be too specific because that is the low-hanging fruit.” 🍌🍌🍌
The assertion implied multiple global Phase 3 partnerships were within reach, yet no subsequent filings, agreements, or official disclosures confirmed any such deals. Analysts later noted that no joint ventures or Phase 3 sites outside the U.S. were ever initiated, making the statement a false promise of near-term expansion.
(2) Annovis Year-End Investor Webcast – December 11, 2024
Dr. Maccecchini made bold and financially misleading claims about Annovis Bio’s funding capacity, asserting that the company was “ready to go” with over
$200 million in available capital, despite SEC filings showing far less liquidity.
She stated:
“We’re ready to go of course the 12M ... we just put in place a 50M ATM facility that will help us ... have raised a total of 14M from the existing ELOCK and we’re planning to draw down another 30M so between the ... are over 200M ... we feel very comfortable that we have the money ... anywhere between the end of the year and April so you will hear shortly how we’re getting the 200M ... or, partnership, so the simple answer is yes, yes, yes, yes, yes.”
This statement gave investors the false impression that Annovis was fully funded for Phase 3 trials and operations, even though subsequent filings and cash flow data revealed severe financial strain and dilution. The vague “yes, yes, yes, yes, yes” refrain served to reinforce investor confidence without substantiation, a hallmark of deceptive financial communication.
(3) Annovis Patients’ Live Forum – February 27, 2025
In a session intended for patients and caregivers, Dr. Maccecchini made an ethically questionable and manipulative appeal, directly urging attendees to purchase stock:
“Buy stock! It’s the ONLY way out!!!”
This statement blurred the line between scientific outreach and financial solicitation, exploiting patient trust. It suggested that the company’s success—and implicitly, their loved ones’ hope—depended on stock purchases, a tactic viewed as highly inappropriate and misleading under securities and medical ethics standards.
#CFODive #MauraWebberSadovi #StatNews #AdamFeuerstein #StephenSedgwickCNBC #ENDALZ #FDA_Drug_Info #GoTeamFox #Parkinsons #Research #FindACure #UnityWalk #OutrunPD #NIH #NIA #SEC
P.S. Annovis Bio has done Maxim Group events before including this one from 2021. IMO, none of these events will advance "her story" which is based on her as an Under Dog ... albeit one with "900% confidence" her drug works!!!
But, with NO robust proof 👈🤨🚩